Stanford inventors in the lab of Dr. Katrin Svensson have discovered an endogenous peptide hormone that shows promise in treating obesity and diabetes.
Stanford inventors in the Katrin Svensson laboratory have identified the protein Isthmin-1 (ISM1) as a treatment for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).